Latest news with #BauschHealthCompanies
Business Recorder
3 days ago
- Business
- Business Recorder
Toronto stocks subdued as investors await pivotal US-Russia meet
Canada's main stock index was flat on Friday as investors awaited a high-stakes meeting between Donald Trump and Russian leader Vladimir Putin on a potential path to ending the war in Ukraine. The Toronto Stock Exchange's S&P/TSX composite index was up 0.03% at 27,924.45 points. Among TSX sub-indexes, healthcare led weekly gains after a 3.7% rise on the day, boosted by a 37% weekly jump in Bausch Health Companies, its biggest rise since May 2023. Materials was the biggest drag, down 0.5%, as gold prices traded with caution ahead of the Trump-Putin talks. The stage was set for the U.S.-Russia summit in Alaska, scheduled for 11 a.m. Alaska time (1900 GMT), to discuss a ceasefire in Ukraine that Washington views as a potential path to ending Europe's deadliest war since World War Two. Trump said a second summit involving Ukrainian President Volodymyr Zelenskiy could follow if the talks go well. 'Short-term investors are hoping at least the meeting brings some kind of ceasefire or at least have continuous talks aswe're moving towards the end of the summer,' said Michael Constantino, CEO at Webull Canada. TSX's moves also mimicked Wall Street's benchmark S&P 500 index, which was largely flat. However, the blue-chip The Dow Jones Industrial Average took the spotlight as it hit an all-time intraday high. Despite the tepid moves, ongoing expectations for U.S. Federal Reserve easing have kept Canadian equities on track to finish the week higher. The TSX is up 0.5% so far this week. Data on Friday showed Canadian factory sales grew 0.3% in June from May, led by petroleum, coal and food products, while wholesale trade rose 0.7% on gains in food, beverage and tobacco. South of the border, retail sales rose by an expected 0.5% in July, but a spike in import prices raised concerns that U.S. tariffs could fuel inflation in the months ahead.
Yahoo
6 days ago
- Business
- Yahoo
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting
We recently published . Bausch Health Companies Inc. (NYSE:BHC) is one of the best-performing stocks on Monday. Bausch Health bounced back by 15.83 percent on Monday to close at $6.66 apiece as investors appeared to have hunted for bargains, having traded below the $6 level for seven days in a row. Monday's share price marked Bausch Health Companies Inc. (NYSE:BHC) first official claw back to the green territory since the start of the month after hovering for most of the trading days below the $5.89 closing price on July 31. It picked up to $5.94 on August 5, but only by a slight 0.85-percent gain from July 31's closing price. Year-to-date, the company's shares were down by 17.4 percent. In recent news, Bausch Health Companies Inc. (NYSE:BHC) expanded its attributable net income by 1,380 percent in the second quarter of the year to $148 million from only $10 million in the same period last year. Revenues also grew by 5 percent to $2.53 billion from $2.4 billion. Copyright: nimon / 123RF Stock Photo For the full-year period, Bausch Health Companies Inc. (NYSE:BHC) raised its revenue guidance to $10 billion to $10.25 billion, as compared with the $9.95 billion to $10.2 billion previously. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
02-08-2025
- Business
- Business Insider
Analysts Are Neutral on Top Healthcare Stocks: Bausch Health Companies (BHC), Sanofi (SNYNF)
Analysts fell to the sidelines weighing in on Bausch Health Companies (BHC – Research Report) and Sanofi (SNYNF – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bausch Health Companies (BHC) TD Cowen analyst Michael Nedelcovych maintained a Hold rating on Bausch Health Companies yesterday and set a price target of $7.00. The company's shares closed last Friday at $5.71. According to Nedelcovych has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -15.8% and a 27.9% success rate. Nedelcovych covers the Healthcare sector, focusing on stocks such as Takeda Pharmaceutical Company, Molecular Partners AG, and Coherus Biosciences. Currently, the analyst consensus on Bausch Health Companies is a Hold with an average price target of $8.33, implying a 44.1% upside from current levels. In a report issued on July 25, Truist Financial also maintained a Hold rating on the stock with a $6.78 price target. Sanofi (SNYNF) Kepler Capital analyst Nicolas Pauillac maintained a Hold rating on Sanofi on July 31 and set a price target of EUR95.00. The company's shares closed last Friday at $92.56, close to its 52-week low of $88.90. According to Pauillac is ranked #974 out of 9914 analysts. Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $127.69, implying a 38.0% upside from current levels. In a report issued on July 17, Deutsche Bank also maintained a Hold rating on the stock with a EUR100.00 price target.
Business Recorder
27-06-2025
- Business
- Business Recorder
TSX hits record high as investors assess economic data
Canada's main stock index inched up to an all-time high on Friday, but losses in heavyweight mining shares kept gains in check, while investors assessed domestic and US economic data. The S&P/TSX composite index was up 0.1% at 26,790.18 points, surpassing Tuesday's record intraday high of 26,780.19. Healthcare stocks led the sectoral gains with a 1.7% rise. Bausch Health Companies, the parent company of contact lens maker Bausch + Lomb, rose 3.1%. On the flip side, mining shares dropped 2.8%, tracking gold that fell to a near one-month low. TSX rises as US delays decision on direct Mideast involvement Gold miners were among the top losers with Lundin Gold falling 7% to the bottom of the main index. Kinross Gold lost 5.7%. Economic data on Friday showed Canada's economy contracted in April on a monthly basis as sectors exposed to tariffs negated a boost from services. The GDP figures are 'being driven by weaker exports to the US … I don't think that's being reflected in the market though,' said Philip Petursson, chief investment strategist at IG Wealth Management. 'It raises the potential for further interest rate cuts.' In the US, consumer spending unexpectedly fell in May, while monthly inflation increases remained moderate. Among individual stocks, TC Energy rose 3.3% after the pipeline operator started collecting tolls for the Southeast Gateway natural gas pipeline in Mexico. Miner Wesdome Gold finished its acquisition of Angus Gold. Shares of Wesdome Gold were down 2.9%.
Yahoo
02-05-2025
- Business
- Yahoo
Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations
Revenue: US$2.26b (up 4.9% from 1Q 2024). Net loss: US$58.0m (loss narrowed by 9.4% from 1Q 2024). US$0.16 loss per share (improved from US$0.17 loss in 1Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 7.9% growth forecast for the Pharmaceuticals industry in the US. Performance of the American Pharmaceuticals industry. The company's shares are down 3.3% from a week ago. You still need to take note of risks, for example - Bausch Health Companies has 1 warning sign we think you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
